Sanofi US recalls Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC, Bridgewate
Recalled August 14, 2013 · FDA recall D-841-2013 · Sanofi US
Hazard
Subpotent drug: low fill volume in some of the capsules · FDA Class II
Units
2,462 bottles
Sold at
Nationwide
Description
Subpotent drug: low fill volume in some of the capsules
Product
Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC, Bridgewater, NJ 08807, NDC 0068-0510-30
Manufacturer(s)
Sanofi US
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →